MCYTOMAG-70K-PMX
MILLIPLEX®小鼠细胞因子/趋化因子磁珠试剂盒 - 预混25重 - 免疫学多重分析
Simultaneously analyze multiple cytokine and chemokine biomarkers with Bead-Based Multiplex Assays using the Luminex technology, in mouse serum, plasma and cell culture samples.
别名:
Luminex® Mouse cytokine immunoassay, Millipore Mouse cytokine immunoassay, Mouse cytokine Multiplex Immunoassay
产品名称
MILLIPLEX®小鼠细胞因子/趋化因子磁珠试剂盒 - 预混25重 - 免疫学多重分析, Simultaneously analyze multiple cytokine and chemokine biomarkers with Bead-Based Multiplex Assays using the Luminex technology, in mouse serum, plasma and cell culture samples.
species reactivity
mouse
manufacturer/tradename
Milliplex®
assay range
accuracy: 85-107%
standard curve range: 3.2-10,000 pg/mL
technique(s)
multiplexing: suitable
compatibility
configured for Premixed
detection method
fluorometric (Luminex xMAP)
shipped in
wet ice
Quality Level
Application
- 分析物：G-CSF, GM-CSF, IFN-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17, IP-10, KC, MCP-1, MIP-1α, MIP-1β, MIP-2, RANTES, TNF-α
General description
为了鉴别参与任何炎症或免疫反应的特定细胞因子，可能有必要筛选细胞因子组，通常需要一定水平的自动化和/或高通量。微珠可以使自动化和高通量筛选过程更容易，并具有自动化洗涤等功能。甚至在自动化之外的优势包括:
MILLIPLEX®小鼠细胞因子/趋化因子组套使您能够专注于细胞因子的治疗潜力以及细胞因子表达的调节。结合微珠格式的Luminex ® xMAP®平台，您可以获得理想的速度和灵敏度的优势，允许同时对数十种分析物进行定量多重检测，从而可以显著提高生产力。
组套类型：细胞因子/趋化因子
- 更柔韧的板和洗板机选择
- 使用浑浊的血清/血浆样品改善性能
- 测定结果等同于非微珠
- 自动洗涤避免了与真空过滤洗涤相关的许多问题
MILLIPLEX®小鼠细胞因子/趋化因子组套使您能够专注于细胞因子的治疗潜力以及细胞因子表达的调节。结合微珠格式的Luminex ® xMAP®平台，您可以获得理想的速度和灵敏度的优势，允许同时对数十种分析物进行定量多重检测，从而可以显著提高生产力。
组套类型：细胞因子/趋化因子
Other Notes
灵敏度：有关单个细胞因子的灵敏度，请参阅试剂盒方案。
Legal Information
Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
target_organs
Respiratory Tract
存储类别
10 - Combustible liquids
法规信息
新产品
此项目有
Christine I Wooddell et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 21(5), 973-985 (2013-02-27)
RNA interference (RNAi)-based therapeutics have the potential to treat chronic hepatitis B virus (HBV) infection in a fundamentally different manner than current therapies. Using RNAi, it is possible to knock down expression of viral RNAs including the pregenomic RNA from
Ruchi Srivastava et al.
The Journal of general virology, 96(Pt 6), 1347-1357 (2015-02-11)
West Nile virus (WNV), an important global human pathogen, targets neurons to cause lethal encephalitis, primarily in elderly and immunocompromised patients. Currently, there are no approved therapeutic agents or vaccines to treat WNV encephalitis. Recent studies have suggested that inflammation
Elena A Govorkova et al.
Antimicrobial agents and chemotherapy, 59(3), 1495-1504 (2014-12-24)
Compounds that target the cellular factors essential for influenza virus replication represent an innovative approach to antiviral therapy. Sp2CBMTD is a genetically engineered multivalent protein that masks sialic acid-containing cellular receptors on the respiratory epithelium, which are recognized by influenza
Dana M Hardbower et al.
Amino acids, 48(10), 2375-2388 (2016-04-15)
We reported that arginase 2 (ARG2) deletion results in increased gastritis and decreased bacterial burden during Helicobacter pylori infection in mice. Our studies implicated a potential role for inducible nitric oxide (NO) synthase (NOS2), as Arg2 (-/-) mice exhibited increased
Kshipra Singh et al.
American journal of physiology. Gastrointestinal and liver physiology, 305(3), G225-G240 (2013-05-25)
L-Arginine (L-Arg) is a semiessential amino acid that has altered availability in human ulcerative colitis (UC), a form of inflammatory bowel disease, and is beneficial in murine colitis induced by dextran sulfate sodium (DSS), a model with similarity to UC.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持